Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Quattrone

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
European Journal of Cancer (Oxford, England : 1990)|February 17, 2019
Adjuvant androgen deprivation therapy for poor-risk, androgen receptor-positive salivary duct carcinomaW van Boxtel, L D Locati, A C H van Engen-van Grunsven, et al.
European Journal of Cancer (Oxford, England : 1990)|November 9, 2016
A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impactL D Locati, F Perrone, B Cortelazzi, et al.
ESMO Open|January 17, 2026
A tailored histology-driven molecular profiling algorithm proposal for salivary gland cancersS Alfieri, S Rota, R Romanò, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Radiochemotherapy for salivary gland adenoid cystic carcinoma: survival assessment through a retrospective study exploiting real-world data extracted from data warehouseS Cavalieri, B Lombardi Stocchetti, N Crippa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 19, 2018
Activity and safety of afatinib in a window preoperative EORTC study in patients with squamous cell carcinoma of the head and neck (SCCHN)J-P Machiels, P Bossi, J Menis, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
European Journal of Cancer (Oxford, England : 1990)|February 17, 2019
Adjuvant androgen deprivation therapy for poor-risk, androgen receptor-positive salivary duct carcinomaW van Boxtel, L D Locati, A C H van Engen-van Grunsven, et al.
European Journal of Cancer (Oxford, England : 1990)|November 9, 2016
A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impactL D Locati, F Perrone, B Cortelazzi, et al.
ESMO Open|January 17, 2026
A tailored histology-driven molecular profiling algorithm proposal for salivary gland cancersS Alfieri, S Rota, R Romanò, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Radiochemotherapy for salivary gland adenoid cystic carcinoma: survival assessment through a retrospective study exploiting real-world data extracted from data warehouseS Cavalieri, B Lombardi Stocchetti, N Crippa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 19, 2018
Activity and safety of afatinib in a window preoperative EORTC study in patients with squamous cell carcinoma of the head and neck (SCCHN)J-P Machiels, P Bossi, J Menis, et al.
Pageof 3